CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications
- Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universitat de Barcelona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Abstract
Somatic copy number alterations (CNAs) are a hallmark of cancer, but their role in tumorigenesis and clinical relevance remain largely unclear. Here we developed CNApp, a web-based tool that allows a comprehensive exploration of CNAs by using purity-corrected segmented data from multiple genomic platforms. CNApp generates genome-wide profiles, computes CNA scores for broad, focal and global CNA burdens, and uses machine learning-based predictions to classify samples. We applied CNApp to the TCGA pan-cancer dataset of 10,635 genomes showing that CNAs classify cancer types according to their tissue-of-origin, and that each cancer type shows specific ranges of broad and focal CNA scores. Moreover, CNApp reproduces recurrent CNAs in hepatocellular carcinoma, and predicts colon cancer molecular subtypes and microsatellite instability based on broad CNA scores and discrete genomic imbalances. In summary, CNApp facilitates CNA-driven research by providing a unique framework to identify relevant clinical implications. CNApp is hosted at https://tools.idibaps.org/CNApp/.
Data availability
Data and plots presented in the submission were generated by using our CNApp tool. Source code and additional files can be found at GitHub (https://github.com/ait5/CNApp).
Article and author information
Author details
Sebastià Franch-Expósito
Funding
CIBEREHD
- Sebastià Franch-Expósito
Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (GCB13131592CAST)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
European Commission /Horizon 2020 Program (HEPCAR Ref. 667273-2)
- Josep Maria Llovet
U.S. Department of Defense (CA150272P3)
- Josep Maria Llovet
National Cancer Institute (P30-CA196521)
- Josep Maria Llovet
Samuel Waxman Cancer Research Foundation
- Josep Maria Llovet
Spanish National Health Institute (SAF2016-76390)
- Josep Maria Llovet
Generalitat de Catalunya/AGAUR (SGR-1162)
- Josep Maria Llovet
Generalitat de Catalunya/AGAUR (SGR-1358)
- Josep Maria Llovet
European Regional Development Fund (PI14/00783)
- Marcos Díaz-Gay
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
European Regional Development Fund (PI17/01304)
- Marcos Díaz-Gay
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (AGAUR 2016BP00161)
- Laia Bassaganyas
European Regional Development Fund (PI17/00878)
- Marcos Díaz-Gay
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (2017 SGR 21)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (2017 SGR 653)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (AGAUR 2018FI B1_00213)
- Marcos Díaz-Gay
Spanish National Health Institute (FPI BES-2017-081286)
- Roger Esteban-Fabró
European Comission (PCIG11-GA-2012-321937)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
European Regional Development Fund (CP13/00160)
- Marcos Díaz-Gay
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
CERCA Program
- Juan José Lozano
- Antoni Castells
- Josep Maria Llovet
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (2017 SGR 1035)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
PERIS Generalitat de Catalunya (SLT002/16/00398)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2020, Franch-Expósito et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 10,144
- views
-
- 511
- downloads
-
- 53
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications
eLife 9:e50267.
https://doi.org/10.7554/eLife.50267
Further reading
-
- Biochemistry and Chemical Biology
- Computational and Systems Biology
Protein–protein interactions are fundamental to understanding the molecular functions and regulation of proteins. Despite the availability of extensive databases, many interactions remain uncharacterized due to the labor-intensive nature of experimental validation. In this study, we utilized the AlphaFold2 program to predict interactions among proteins localized in the nuage, a germline-specific non-membrane organelle essential for piRNA biogenesis in Drosophila. We screened 20 nuage proteins for 1:1 interactions and predicted dimer structures. Among these, five represented novel interaction candidates. Three pairs, including Spn-E_Squ, were verified by co-immunoprecipitation. Disruption of the salt bridges at the Spn-E_Squ interface confirmed their functional importance, underscoring the predictive model’s accuracy. We extended our analysis to include interactions between three representative nuage components—Vas, Squ, and Tej—and approximately 430 oogenesis-related proteins. Co-immunoprecipitation verified interactions for three pairs: Mei-W68_Squ, CSN3_Squ, and Pka-C1_Tej. Furthermore, we screened the majority of Drosophila proteins (~12,000) for potential interaction with the Piwi protein, a central player in the piRNA pathway, identifying 164 pairs as potential binding partners. This in silico approach not only efficiently identifies potential interaction partners but also significantly bridges the gap by facilitating the integration of bioinformatics and experimental biology.
-
- Computational and Systems Biology
- Neuroscience
Accumulating evidence to make decisions is a core cognitive function. Previous studies have tended to estimate accumulation using either neural or behavioral data alone. Here, we develop a unified framework for modeling stimulus-driven behavior and multi-neuron activity simultaneously. We applied our method to choices and neural recordings from three rat brain regions—the posterior parietal cortex (PPC), the frontal orienting fields (FOF), and the anterior-dorsal striatum (ADS)—while subjects performed a pulse-based accumulation task. Each region was best described by a distinct accumulation model, which all differed from the model that best described the animal’s choices. FOF activity was consistent with an accumulator where early evidence was favored while the ADS reflected near perfect accumulation. Neural responses within an accumulation framework unveiled a distinct association between each brain region and choice. Choices were better predicted from all regions using a comprehensive, accumulation-based framework and different brain regions were found to differentially reflect choice-related accumulation signals: FOF and ADS both reflected choice but ADS showed more instances of decision vacillation. Previous studies relating neural data to behaviorally inferred accumulation dynamics have implicitly assumed that individual brain regions reflect the whole-animal level accumulator. Our results suggest that different brain regions represent accumulated evidence in dramatically different ways and that accumulation at the whole-animal level may be constructed from a variety of neural-level accumulators.
